Medicine Man Technologies Inc (MDCL) Return on Assets ROA from the fourth quarter of 2023 to fourth quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Dec 31 2023 to Dec 31 2022 - CSIMarket
CSIMarket
 


Medicine Man Technologies inc   (MDCL)
    Sector  Services    Industry Consulting Services
   Industry Consulting Services
   Sector  Services


Medicine Man Technologies Inc 's ROA from the fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Medicine Man Technologies Inc 's ROA in the fourth quarter of 2023?
Medicine Man Technologies Inc recorded a cumulative net loss of $-42 million during 12 months ending in the fourth quarter of 2023, resulting in a negative return on assets (ROA) of -12.53%.

However, within the Services sector 563 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2023 from 3583 to 4012.

What is ROA?



Return On Assets (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Total Assets Change 6.37 % 18.73 % 12.86 % -4.14 % 6.97 %
Y / Y Net Income Change - 1826.84 % - - -
Net Income (TTM) in million -42 -37 -37 4 -24
Return On Assets (TTM) -12.53 % -11.06 % -11.71 % 1.24 % -7.85 %
MDCL's Total Ranking # 4012 # 3583 # 3709 # 2420 # 4122
Total Assets (TTM) in million 326 371 348 305 306
Seq. Total Assets Change -12.13 % 6.64 % 13.83 % -0.28 % -1.92 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 25
Sector # 564
Overall # 3926

Return On Assets Statistics
High Average Low
20.61 %
-16.58 %
-67.65 %
(Sep 30 2018)   (Sep 30 2019)





Financial Statements
Medicine Man Technologies Inc 's Assets $ 326 million MDCL's Balance sheet
Medicine Man Technologies Inc 's Income $ -33 million Quarterly MDCL's Income Statement
MDCL's Income by Division See MDCL's Income by Division



Annual Return On Assets (Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
(Dec 31 2020)
FY 2020
(Dec 31 2019)
FY 2019
Y / Y Total Assets Change 6.37 % 6.97 % 304.91 % 123.82 % 97.1 %
Total Assets in million 326 306 286 71 32
Y / Y Net Income Change - - - - -
Net Income in million -43 -26 15 -20 -17
Annual Return On Assets -13.11 % -8.58 % 5.07 % -28.74 % -53.75 %




More Return On Assets Ratios
MDCL's' Return on Assets at Yahoo Finance
Consulting Services Industry Return On Assets Trends and Statistics
Services Sector Roa Statistics
Roa Trends for overall market
MDCL's Roa Ratio versus Consulting Services Industry, Services Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MDCL's Competitors
Subscribers only: Roa for Medicine Man Technologies Inc 's Suppliers
Subscribers only: Return On Assets for MDCL's Customers

You may also want to know
MDCL's Roi MDCL's Inventory Turnover Ratio MDCL's Growth Rates MDCL's Dividend Comparisons
MDCL's Profitability Ratios MDCL's Asset Turnover Ratio MDCL's Dividend Growth
MDCL's Roe MDCL's Valuation Ratios MDCL's Financial Strength Ratios MDCL's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2023, within Services Sector ROA


Date modified: 2026-08-31T04:25:24+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.